| __timestamp | Biogen Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 14182353 |
| Thursday, January 1, 2015 | 2012800000 | 15503028 |
| Friday, January 1, 2016 | 1973300000 | 16183585 |
| Sunday, January 1, 2017 | 2253600000 | 22382849 |
| Monday, January 1, 2018 | 2597200000 | 33038206 |
| Tuesday, January 1, 2019 | 2280600000 | 31777040 |
| Wednesday, January 1, 2020 | 3990900000 | 41464134 |
| Friday, January 1, 2021 | 2501200000 | 67178053 |
| Saturday, January 1, 2022 | 2231100000 | 52531000 |
| Sunday, January 1, 2023 | 2702600000 | 68914000 |
| Monday, January 1, 2024 | 2041800000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Biogen Inc. and Pharming Group N.V. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Biogen consistently outspent Pharming Group, with its R&D expenses peaking in 2020 at nearly $4 billion, a staggering 5,700% more than Pharming's $41 million that year. Despite this disparity, Pharming Group has shown a steady increase in its R&D budget, growing by nearly 385% from 2014 to 2023. This trend highlights the diverse strategies within the pharmaceutical sector, where both giants and smaller players strive to innovate and bring new therapies to market. As we look to the future, these investments will likely shape the landscape of medical advancements and patient care.
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Biogen Inc. or Insmed Incorporated: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Research and Development Expenses Breakdown: Biogen Inc. vs Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Pharming Group N.V. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.